Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Oct 4, 2022--
The "Precision and Personalized Medicine - Thematic Research" report has been added to ResearchAndMarkets.com's offering.
This report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats. Inside, we predict how each theme will evolve and identify the leading and disrupting companies. The report covers the Precision Medicine theme.
Precision and Personalized Medicine refers to a medical model that proposes the customization of healthcare, allowing medical treatment plans to be tailored to each individual patient based on various characteristics. These characteristics often include genetic information as well as the patient's lifestyle and environment.
Historically, clinicians have used factors such as symptoms and medical history of a patient throughout the diagnostic and treatment phase. While this is still helpful information, these factors alone tend to favor a 'one size fits all' approach in medicine.
With the use of precision and personalized medicine, clinicians will not only consider symptoms and medical history, but also the patient's genetics, environment, biomarkers, and more. With these additional factors, patients will have diagnoses, treatment, and prevention methods that are suited to them and potentially more effective.
Precision and personalized medicine can reshape disease treatments and provide better treatment options to patients. A major factor contributing to this ability is the use of data and genomics to tailor healthcare plans to each patient. This involves finding the best possible drugs and procedures for the patient and extends to prevention and diagnosis.
At present, precision and personalized medicine is most often used in oncology. However, there are many other diseases and areas in medicine that would benefit significantly from this medical model.
Reasons to Buy
Key Topics Covered:
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/oxa4lx
View source version on businesswire.com:https://www.businesswire.com/news/home/20221004005718/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 10/04/2022 08:23 AM/DISC: 10/04/2022 08:23 AM
http://www.businesswire.com/news/home/20221004005718/en